BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15379719)

  • 1. The sodium-iodide symporter.
    Baker CH; Morris JC
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Sep; 4(3):167-74. PubMed ID: 15379719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The practical relevance of the sodium iodide symporter].
    Spitzweg C
    Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():25-32. PubMed ID: 15255310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The sodium-iodide symporter. Pathophysiologic, diagnostic and therapeutic significance].
    Spitzweg C
    Internist (Berl); 2003 Apr; 44(4):396-402, 404-8, 410-1. PubMed ID: 12914397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sodium iodide symporter: its pathophysiological and therapeutic implications.
    Spitzweg C; Morris JC
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):559-74. PubMed ID: 12390328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond.
    Dohán O; Carrasco N
    Mol Cell Endocrinol; 2003 Dec; 213(1):59-70. PubMed ID: 15062574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sodium/iodide symporter: state of the art of its molecular characterization.
    Darrouzet E; Lindenthal S; Marcellin D; Pellequer JL; Pourcher T
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):244-53. PubMed ID: 23988430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
    Schmutzler C; Köhrle J
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A perspective view of sodium iodide symporter research and its clinical implications.
    Riesco-Eizaguirre G; Santisteban P
    Eur J Endocrinol; 2006 Oct; 155(4):495-512. PubMed ID: 16990649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium iodide symporter: its role in nuclear medicine.
    Chung JK
    J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sodium/iodide symporter: physiopathological aspects and therapeutic perspectives].
    Plantin-Carrenard E; Foglietti MJ; Beaudeux JL
    Pathol Biol (Paris); 2005 Apr; 53(3):174-82. PubMed ID: 15781380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complex regulation of NIS expression and activity in thyroid and extrathyroidal tissues.
    Riesco-Eizaguirre G; Santisteban P; De la Vieja A
    Endocr Relat Cancer; 2021 Sep; 28(10):T141-T165. PubMed ID: 34387194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.
    De La Vieja A; Dohan O; Levy O; Carrasco N
    Physiol Rev; 2000 Jul; 80(3):1083-105. PubMed ID: 10893432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.
    Ravera S; Reyna-Neyra A; Ferrandino G; Amzel LM; Carrasco N
    Annu Rev Physiol; 2017 Feb; 79():261-289. PubMed ID: 28192058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology and clinical application of the NIS gene.
    Elisei R; Vivaldi A; Pacini F
    Tumori; 2003; 89(5):523-8. PubMed ID: 14870777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium iodide symporter-based strategies for diagnosis and treatment of thyroidal and nonthyroidal malignancies.
    Heufelder AE; Morgenthaler N; Schipper ML; Joba W
    Thyroid; 2001 Sep; 11(9):839-47. PubMed ID: 11575853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in gastric sodium-iodide symporter (NIS) activity are associated with differences in thyroid gland sensitivity to perchlorate during metamorphosis.
    Carr JA; Murali S; Hu F; Goleman WL; Carr DL; Smith EE; Wages M
    Gen Comp Endocrinol; 2015 Aug; 219():16-23. PubMed ID: 25448256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells.
    Lundh C; Lindencrona U; Postgård P; Carlsson T; Nilsson M; Forssell-Aronsson E
    J Nucl Med; 2009 Jul; 50(7):1161-7. PubMed ID: 19525464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of correlation for sodium iodide symporter mRNA and protein expression and analysis of sodium iodide symporter promoter methylation in benign cold thyroid nodules.
    Neumann S; Schuchardt K; Reske A; Reske A; Emmrich P; Paschke R
    Thyroid; 2004 Feb; 14(2):99-111. PubMed ID: 15068624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance.
    Dohán O; De la Vieja A; Paroder V; Riedel C; Artani M; Reed M; Ginter CS; Carrasco N
    Endocr Rev; 2003 Feb; 24(1):48-77. PubMed ID: 12588808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular study of the sodium-iodide symporter (NIS): a new field in thyroidology.
    Dohan O; De la Vieja A; Carrasco N
    Trends Endocrinol Metab; 2000 Apr; 11(3):99-105. PubMed ID: 10707050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.